The Aspects of Gene Therapy Lecture Notes
The Aspects of Gene Therapy Lecture Notes
The Aspects of Gene Therapy Lecture Notes
LESSON OVERVIEW
This lesson will discuss Gene Therapy concepts and its potential benefits and
disadvantages to global health.
Defective genes were related to many human diseases. These diseases cannot be
cured by traditional methods like taking readily available medicines. Gene therapy is a
potential method to either treat or cure genetic – related human illnesses. In 2015, a team of
researchers at the Harvard Medical School and the Boston Children’s hospital has restored
the hearing of genetically deaf mice thru gene therapy. The research team in Boston Children’s
Hospital also reported that they bring back a higher level of hearing - down to 25 decibels
which is the same as a whisper. The “Anc80”, is an improved gene therapy vector developed
at the Massachusetts Eye and Ear which enables the transfer of genes to the inaccessible
outer hair cells when introduced into the cochlea.
In 1971, human gene therapy was first realized. That year, the first recombinant DNA
experiments were planned. This is done by simply inserting foreign DNA into a patient’s tissue
that hopes to remove the targeted disease. It was inspired by the success of recombinant
DNA technology which occurred over the last 20 years. Without a doubt, gene therapy is the
most promising yet possible unfavorable medical field being studies.
In general, a gene cannot be directly inserted into a human gene or cell. A gene is
usually inserted into another gene using a carrier or vector. Nowadays, viruses are used,
after it has been genetically changed, to carry normal human DNA. It has been identified
that viruses have a way of encapsulating the genes in cells that will be helpful to the patient
but not inherited to the next generation.
2. Germ-line Therapy
This therapy involves the genetic modification of germ cells or the origin cells that
will pass the change on to the next generation
Until a stem cell is activated by disease or tissue injury, it will remain non-dividing for
years. These stem cells can divide or self – renew indefinitely, enabling them to generate a
range of cell types from the originating organ or even regenerate the entire original organ. It
is generally thought that adult or somatic stem cells are limited in their ability to
differentiate based on their tissue of origin, but there is some evidence to suggest that they
can differentiate to become other cell types.
The first death associated with gene therapy occurred on September 18, 1999, at the
University of Pennsylvania. Jesse Gelsinger was participating in a clinical trial, a biomedical
experiment for evaluation of safety and efficiency of a therapy for a disease. Gelsinger, who
was 18 years old at the time of the treatment, had a deficiency of ornithine transcarboamylase,
an important enzyme in the metabolism of ammonia. Patients with this rare metabolic disorder
must maintain a low-protein diet and take a series of medicines to avoid ammonia poisoning
in the blood stream. The gene therapy Gelsinger took triggered a chain reaction in his immune
system, resulting in hepatic and respiratory failure, and consequently, his death four days after
being treated.
Effects on Human
Looking at the fact that genetic engineering employs viral vector that carries functional
gene inside the human body; the repercussion are still unknown. There are no clues as to
where functional genes are being placed. They may even replace the important genes, instead
of mutated genes. Thus, this may lead to another health condition or disease to human. Also,
as defective genes are replaced with functional gene, then it is expected that there will be a
reduction in genetic diversity and if human beings will have identical genomes, the population
as a whole will be susceptible to virus or any form of diseases.
Antibiotic Resistance
Genetic engineering often uses genes for antibiotic resistance as "selectable markers."
Early in the engineering process, these markers help identify cells that have taken up foreign
genes. Although they have no further use, the genes continue to be expressed in plant tissues.
Most genetically engineered plant foods carry fully functioning antibiotic-resistance genes.
The presence of antibiotic-resistance genes in foods could have lethal effects.
Therefore, eating these foods could reduce the effectiveness of antibiotics to fight disease
when these antibiotics are taken with meals. More so, the resistance genes could be
transferred to human or animal pathogens, making them impervious to antibiotics. If transfer
were to occur, it could aggravate the already serious health problem of antibiotic resistant
disease organisms.